Sermo's 'Yelp for drugs' platform chalks up 665K doctor reviews in just 1 year
fiercepharma | April 30, 2018
Sermo’s drug-rating system by doctors for doctors is soaring. A little less than a year after its launch, the Yelp-like platform now has 655,000 ratings on more than 4,000 medications, CEO Peter Kirk tells us. More than half those drugs have at least 100 reviews and 18 of them have more than 1,000. For pharma companies, the database has come to serve as real-time feedback on physicans’ experiences with their particular drugs. It’s also a way to evaluate brand equity, check reactions to promo and educational messaging, and get competitive intelligence.